The Ministry of Health (MOH) invites healthcare professionals to access clinical evidence summaries which are being developed in response to emerging evidence on potential therapeutic options for COVID-19 on the MOH website at https://www.moh.gov.sg/covid-19/clinical-evidence-summaries

1. As there is a lot of information on the internet which may not be accurate, MOH encourages healthcare professionals to refer to the evidence summaries to obtain the most updated information. As the situation is evolving rapidly, the clinical summaries will be updated regularly as new evidence emerges.

2. Ten evidence summaries are currently uploaded on the MOH website:

• PCR Testing for COVID-19: Where to Swab?
• Should Convalescent Plasma be Used for COVID-19?
• Should Baricitinib be Used for COVID-19?
• Should Favipiravir be Used for COVID-19?
• Should Protease Inhibitors be Used for COVID-19?
• Should Remdesivir be Used for COVID-19?
• Should Interleukin-6 Inhibitors be Used for COVID-19?
• Can Antimalarials be Used to Treat COVID-19?
• Should Ibuprofen be Used for COVID-19?
• Should ACE Inhibitors and Angiotensin II Receptor Blockers be Stopped for COVID-19?

3. If you have any enquiries/have a clinical topic that they would like ACE to review, they are welcome to email the Secretariat at MOH_DAC_Secretariat@moh.gov.sg.